CIRCADIAN VARIATIONS IN CYTOKINES AND THE EFFECT OF TIMED RELEASE TABLET PREDNISONE IN POLYMYALGIA RHEUMATICA.
Phase of Trial: Phase II/III
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Prednisone (Primary)
- Indications Polymyalgia rheumatica
- Focus Pharmacodynamics
- 04 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 18 Sep 2014 New source identified and integrated (ClinicalTrials.gov; NCT00836810).
- 04 Aug 2011 New trial record